Integra LifeSciences (NASDAQ:IART – Get Free Report) updated its FY24 earnings guidance on Monday. The company provided earnings per share (EPS) guidance of $2.41-2.57 for the period, compared to the consensus estimate of $3.04. The company issued revenue guidance of $1.609-1.629 billion, compared to the consensus revenue estimate of $1.68 billion. Integra LifeSciences also updated its FY 2024 guidance to 2.410-2.570 EPS.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.